Digital health innovations
We are actively seeking proven digital innovations that improve the health of people in the region and raise the quality, efficiency, safety and cost-effectiveness of delivering healthcare.
We are particularly interested to hear about innovations in the following categories:
  • Health maintenance - supporting people in maintaining their physical and mental wellbeing,
  • Prevention - alerting patients, carers or professionals when there are signs that things aren’t going well, and an intervention can prevent crises or emergencies
  • Access - providing more convenient and cost-effective ways for patients and professionals to interact. (e.g. remote monitoring or virtual consultations).
  • Learning and education - delivering information and knowledge to patients about their health or condition, or to professionals to support their continuous professional development
  • Pathways - providing tailored information to patients, carers and professionals on services to signpost people to the most appropriate place.  Ideally, this could be enhanced with real-time information about capacity.
  • Research - using digital tools to promote involvement in research & clinical trials, to streamline the capture of informed consent, and to capture research data more efficiently and conveniently.
  • Integration - tools that enable the secure, appropriate sharing of information between organisations (e.g. GPs and hospital clinicians) and sectors (e.g. NHS and Social Services) to allow patients to receive seamless care.
  • Data Visualisation - innovative ways of presenting information in a meaningful way to enable more informed decisions by patients and professionals.  This may involve aggregating data from different sources, reporting tools or graphic visualisations such as heat maps.

Ideas (Wellness and prevention of illness)

Discharge Accelerator (#3013)
Innovation 'Elevator Pitch':
Kemuri portable K-Sockets have a 500% return on investment in one year. Use them to accelerate hospital discharge of elderly or frail people into reablement by social services.
Overview of Innovation:



Kemuri K-Sockets are power sockets with multiple sensors that continuously measure:
  • Movement of people in the kitchen;
  • Electrical power for kettles, microwaves or toasters;
  • Room temperature;
  • Power supply.
They send data via the Internet via GSM mobile phone communications.  Kemuri software learns patterns of normal activity and analyses Activities of Daily Living (ADLs) every hour.  As soon as the system identifies too many changes from normal, it automatically alerts people who need to respond to possible risks.  Responders can be families, carers or 24/7 alarm response centres.

The WebApp gives evidence of reablement of the service users.  It gives confidence to responders who have been given informed consent to view the data.  For example:
  • Wandering or unattended falls: Kemuri alerts non-return to kitchen;
  • Nutrition & Hydration: Kemuri alerts risk of dehydration or malnutrition;
  • Engaged the Community: Kemuri apps are free to authorised family, carers or voluntary sector;
  • Active in the home: If people can eat, drink and move around in warm surroundings – then they are performing key ADLs.
Portable K-Sockets are allocated to discharge teams as part of the normal hospital discharge process. Families or other carers have to respond to alerts and determine the action to be taken.  The devices are re-allocated to patients every 6 weeks. Thereafter fixed K-Sockets can be installed in kitchens as wellbeing monitors. 



The cost is less than £500 per year, and the notional saving on bed days is approximately £400 per day.  By using a unit eight times per year, more than £3200 budget is released for more patients.  This represents more than 500% return on investment in one year.  This must be worth a trial in the region.  Additional benefit can come from reduced re-admissions.

Surrey County Council have awarded a grant of £50,000 for measuring the reablement process and subsequent wellbeing monitoring.
Stage of Development:
Evaluation stage - Representative model or prototype system developed and can be effectively evaluated
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Two areas of immediate benefit are the saving of excess bed days for non-medical reasons and the avoidance of re-admission. 
  • Many elderly and frail people cannot be safely discharged from hospital without a period of reablement by family members or professional domiciliary carers.  The NHS typically funds this for a maximum of six weeks – at lower cost than the occupation of a hospital bed.  After assessment and transfer of care to social services, continuous monitoring by K-Sockets permits safe discharges a day or more earlier.  This eases the problems of Bed Managers seeking to release beds for new patients.
  • During reablement, automatic alerts warn of unusual changes of activity.  They could indicate the risk of unattended falls, dehydration, malnutrition of hypothermia; all costly to the NHS.  Appropriate action could avoid the need for re-admission.  
Kemuri is designed for both family carers and 24/7 response services.  Portable K-Sockets require zero installation time and do not require broadband.  Monitoring and machine learning starts within minutes and any people with consent for data sharing can immediately view the data or receive alerts.
 
Longer-term benefits come from wellbeing monitoring after reablement.  Portable K-Sockets can be replaced by fixed K-Sockets.  The data analysis could reveal medical problems, such as UTIs, and preventive action could avoid more costly treatments.    
Initial Review Rating
3.00 (1 ratings)
Benefit to WM population:
Most older people want to return to their own homes as soon as possible after treatment.  Unfortunately, for some independent people, they cannot be discharged because there is no care provision at home.  Perhaps they have no local family or friends.  Consenting to reablement monitoring by K-Sockets could accelerate their discharge and improve health outcomes. 

Families also obtain peace of mind, whether they live locally or at great distances.  At any time of day, people can be alerted to possible problems and respond appropriately.  Most frequently it may only require a reassuring phone call.  On other occasions it could be an unattended fall or medical event that needs clinical action.  Earlier treatment leads to better health outcomes.

It may be possible to reduce the costs of domiciliary care with more-timely and less frequent visits. 
This is an example screen:


A green day shows normal activity.  An amber day shows more changes from normal activity – but may not be cause for alarm.  Red days are alerted during the day and are a call for action.  Viewers can drill down to more detail, and the screen below could indicate the risk of hypothermia.

K-Sockets are invaluable as passive monitors to supplement active telecare devices, such as pendant alarms.  The latter are not worn continuously by 90% of the people who have them and they need reasonable cognition to use them when necessary.  K-Sockets are not stigmatising and do not require any change of lifestyle.

For more information and downloads see http://www.kemurisense.com


 
Current and planned activity: 
Cornwall Council is trialling 20 portable K-Sockets for reablement.  In one case, an alert was sent to a family member before they knew about an unattended fall.
 
Surrey County Council have awarded a grant for TECS Innovation.  The plan is to supply 40 portable K-Sockets for reablement and then supply 100 fixed K-Socket to vulnerable people for six months.  Social Care will perform assessments as part of their normal case management.  An anonymised log of each service user should provide evidence of the bed days saved.  Statistics of readmission or transfer to full-time residential care can be compared to current averages.
 
Many K-Sockets are operational in small trials and some are still operational after years of use in private houses and housing association properties.  They could collect data for several years in long-term trials for clinical trials, such as for drugs for relieving the symptoms of dementia.
What is the intellectual property status of your innovation?:
Kemuri has patents pending; GB1417259.7, effective date of 30 September 2014 and PCT/GB2015/000275, International Filing Date of 30 September 2015. 
 
Kemuri, KemuriSense, K-Sockets and K-Fobs are registered trademarks. 
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
K-Sockets can be produced in batches of 100 to 1000 from a factory in Woking.  If demand rises, second sourcing could be obtained in the WM region.
 
Web services are cloud-based and rapidly scaled at short notice.  Surrey has the largest scale implementation, which should peak at 140 units.  Scale-up should start by engaging with hospital discharge units and reablement teams.  Services to self-funders and Local Authorities can be scaled up by using the larger telecare service companies who provide other equipment and 24/7 call centres. 
Measures:
Quality
  • Alerting the risk of unattended falls, dehydration, malnutrition and hypothermia;
  • Continuous reliable operation
  • Avoidance of false alerts
  • Identifying unusual activity that may indicate need for medical intervention, eg for UTIs or TIAs.
 
Safety
  • Responding to alerts in time to minimise poor health outcomes;
  • Reduction in re-admissions.
 
Cost
The cost of deploying a portable K-Socket is less than £500 per year.  If this saves an average of one excess bed day per month, then the notional return on investment will more than 500%. 
 
People
The target service users are older people awaiting discharge from hospital who:
  • Need initial support from reablement teams;
  • Live independently and do not normally have daily visitors;
  • Can respond to phone calls;
Responders to alerts may be family members, carers or 24/7 response centres.
 
Ethics
Service users must give informed consent for data sharing with approved people such as practitioners, domiciliary cares and family members.
Adoption target:
West Midlands has a population of 5 million.  Engaging 1000 suitable service users per year is a reasonable target.  100 portable K-Sockets is a minimum viability level.  If successful, then growth to 10,000 service users is practical.   
Read more
Hide details
Leonard Anderson 10/10/2018 - 08:10 Detailed Submission Login or Register to post comments
0
0
Votes
1
2
3
4
5
6
-99999
Cera Care (#2918)
Innovation 'Elevator Pitch':
Cera is a multi-award winning, technology-enabled homecare provider. Our technology allows us to respond and deliver tailored care within hours of an enquiry, while empowering our care-workers to deliver the highest standards of care.
 
Overview of Innovation:
Cera is a digital disruptor of the home care space, with in-house and proprietary technology. We have created a platform able to i) create digital care reports whereby during a carer visit, carers log information on their smartphone using our platform, with health and behaviour data on the user, which allows for metrics to be monitored and better care to be delivered – this data is also accessible to family members and healthcare professionals permitting much better connected services; ii) use of artificial intelligence based on the data collected by carers, to predict if users are going to experience health deteriorations such as their blood pressure worsening or the onset of a urine infection, based on subtle signals that carers may have logged – this allows us to escalate a service user’s care should they be at high risk of deterioration, or contact their doctor more proactively, potentially preventing adverse health events or the need to go to hospital; iii) use of an artificial intelligence chatbot – Martha – that provides decision support to carers based on questions they ask. The chatbot aims to transfer some of the knowledge and experience which established carers possess to carers with less experience; by doing this, we aim to make care more consistent.

Cera has provided hundreds of thousands of care hours with a 95% satisfaction rating, and is growing at an average of 25% a month. It has received over £13 million of funding from investors such as Kairos Ventures, Kima Ventures, David Buttress (former CEO of JustEat), Paul Wilmott (leads digital globally for McKinsey), Charles Songhurst (former Global Head of M&A at Microsoft) and Peter Sands (former Chairman of Davos). It has been recognised by the Government's Cabinet Office as a role model for innovative businesses partnering with the public sector, and Sir Nick Clegg recently joined the company. Cera has received a number of awards including the Most Outstanding Digital Health Innovation of the Year, the LaingBuisson Dementia Care Award, the Best London Home Care Company at the Social Care Awards 2018.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
We are the pioneer of innovative care delivery and have been widely recognised as the UK’s leader in transforming the sector. So far we have delivered hundreds of thousands of care sessions with a 95% satisfaction rating. Crucially, we are often able to start care within 24 hours when requested; this is markedly faster than other companies who take 3-4 weeks, and means that healthy people do not need to stay in hospital waiting for their care to be arranged.
We are developing a Artificial Intelligence platform that utilises data collected by carers to predict if users are going to experience health deteriorations, such as their blood pressure worsening or the onset of a urine infection. This allows us to escalate a user’s care should they be at high risk of deterioration, or contact their doctor more proactively, potentially preventing adverse health events. We are also developing an artificial intelligence chatbot that provides decision support to carers based on questions they ask. The chatbot aims to transfer some of the knowledge and experience which established carers possess to carers with less experience.

At present, clinical doctors are not involved in the active review of our clients’ data. However, there are several members of our clinical care team that review reports from each care visit through our digital care platform. Furthermore, using our digital care platform - where data is stored and viewable - it is possible for us to allow GPs and hospital doctors to access the information relating to their own clients. This would be after authenticating themselves on our platform and be possible through our portal website. We are exploring partnerships with Clinical Commissioning Groups which would allow these data sharing partnerships to be made possible.  ​
 
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
We are offering a better experience for our carers, who are offered flexible working and are empowered using technology, translating to an annual carer retention rate of over 90%. We achieve that by paying them up to 50% more than industry average, and supporting their learning via a combination of in-class and online teaching. Our e-learning platform, Learning Pool, has been very successful in engaging our carers to further their knowledge, improving the overall standards of care we provide.  

The care workers are periodically in touch with family members and are certainly aware of important care-related matters through the family members before they begin care. Care workers and family members always have the option to contact each other immediately through Cera Care at any time. Family members can access the visit reports completed by care workers through our portal as soon as they are completed - we believe this gives them a level of transparency that is simply not possible without a digitised solution. We have a comprehensive and clear consent process which all clients must sign before we deliver any care. The scope of this consent covers data capture by care workers, data storage on our platform and processing such as this for the purpose of improving patient care.
 
Our machine learning algorithm is also a work in progress - currently in prototype form. It uses data from the client’s care plan (past medical history, medication, important disabilities, care schedule) and visit reports captured by visiting care workers (mood, nutrition, hydration, activity level, sleep, bowel movements) to attempt to predict when clients are at high risk of experiencing a deterioration in their health. Currently it has an AUC ROC of 0.72. As we collect more data, we will continue to improve its performance. Since we have not operationalised this prototype, we do not require ethics approval and it is not considered a medical device because it does not offer medical diagnostic capability nor does it actively conduct treatment. If we decided to use it to inform our care workers’ practices - we can register it as a Class I device.
Current and planned activity: 
In 2018 we have delivered NHS CCG funded care with the following CCGs: Lambeth, Tower Hamlets, Haringey, Enfield, and previously had partnered with CCGs including Brent, Harrow and Hillingdon, and East London Foundation Trust, in addition to marketing in NHS hospitals including: Central Middlesex, West Middlesex, Northwick Park, Royal Marsden, Whittington and Barnet & Chase Farm and a Marketing Agreement with BMI hospitals across London. NHS 111 is exploring a collaboration with Cera. One potential outcome of this would be to permit the integration of data records from Cera into the 111 service
What is the intellectual property status of your innovation?:
We own IP for our Digital Care Platform and algorithm
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
3 years +
Ease of scalability: 
3
Read more
Hide details
Sara Sliwinska 09/07/2018 - 15:00 Publish 2 comments
5
1
Votes
1
2
3
4
5
6
-99999
CliniTouch Vie: digital remote clinical monitoring (#2898)
Innovation 'Elevator Pitch':
Clinical decision making improved via proactive digital remote monitoring. Together driving cost efficiencies, improving patient outcomes & avoiding hospital admissions. (CE Class 1a: data server sits within HSNC:  proven ¯ 67% admissions: scalable)
Overview of Innovation:
CliniTouch Vie is a digital health solution that reduces unnecessary hospital admissions.
 
CliniTouch Vie is a locked-down tablet with integrated 3G for intensive monitoring, education & empowerment with integrated direct messaging & video support.  Dynamic care plans & evidence-based algorithms enable automatic triage for healthcare teams.  Fast & simple to implement for the most at-risk patients. 
 
Launched in 2016, system is CE marked & MHRA approved. An evidence based digital health platform that clinically supports patients to better manage their condition. It has the flexibility to be adapted for data analytics & clinical decision-making support in chronic disease management (eg COPD, heart failure & diabetes), frailty & assisted discharge programmes for ambulant & non-ambulant patients
 
Clinical & economic evidence has been generated from trials with 300 respiratory patients [Ghosh et al, 2016, https://doi.org/10.12968/bjhc.2016.22.3.123]. Our evidence based digital solution increases patient access to care & promotes greater clinician-patient collaboration for the 15million people with LTCs. It drives timely, proactive intervention, minimising need for more acute costly care enabling sustainable long-term outcomes success
 
USPs:
Evidence based: Study published in the British Journal of HC Management showed 67% reduction in unscheduled COPD admissions & saving of £2,278 per patient pa. (NB: programme continues to deliver same level of savings)
 
Patient-centred: Personalisation of goals, metrics & parameters makes system truly patient centred providing real-time remote monitoring closer to home to improve patient experience & outcomes whilst generating savings
 
Secure & integrated: Data server sits within HSNC enabling it to push-pull data securely between healthcare provider & service users. Includes bespoke integrated secure video-conferencing platform with end-to-end encryption, allowing remote monitoring of medical conditions, improving quality of life & avoiding unnecessary admissions
 
Flexible Modular Architecture: Enables clinically validated question sets re: symptoms, to be easily tailored to specific therapy areas for qualitative data collection
 
Tiered Service: no upfront costs to NHS on PAYG basis:
- Digital platform integrated into existing healthcare pathways
- Light touch triage service informing local health teams of urgent priority patients for interventions
- Fully-Managed digital platform and nurse-led service providing triage & interventions
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
CliniTouch Vie has proven benefits and can be scaled up easily across the wider regions:
  • improved patient outcomes:
  • 67% reduction in COPD emergency admissions;
  • 13% improvement in CAT score
  • 97% of patients using CliniTouch Vie will further reduce distress and discomfort from conditions exacerbations
These were supported by:
  • improved access to healthcare: 24/7 access to healthcare, average 110 interventions per patient per annum (500% increase)
  • targeted and personalised health interventions: 7,250 personalised clinical interventions (data from 66 patients over 12 months)
  • data analytics: real-time clinical dashboards for clinical teams to prioritise patient needs; prioritised only 38% of patient clinical recordings required intervention within a 24-hour period
 

 
Patients are educated and supported to interpret the data to gain an improved understanding of their health status.CliniTouch Vie:
  1. Educates patients: supporting people to make health life choices through improving the understanding of their disease and self-management skills
  2. Enhances care for patients with chronic conditions: informing and engaging patients as part of NHS prevention agenda and creating a patient-provider collaboration
  3. Provides data analytics: making more targeted and personalised health interventions, by using disease specific algorithms to differentiate when one patient’s history or recent environmental exposures indicates a higher likelihood of flare up than another
  4. Improves patient safety: providing real time clinical and well-being data to identify early warning signs of health deterioration, medication adherence and self-management education
  5. Reduces hospital activity: providing real time management of high risk patients to prevent admissions
  6. Supports early discharge: providing hospital level diagnostics and monitoring in the home, enabling early discharge and can be used for remote clinical support post-surgery or in care-home settings
  7. Delivers workload efficiencies: supporting better patient self-management, reducing need for direct interventions and enabling staff to focus on priority patient care
  8. Offers locality wide cost savings: reduced demand leads to reduced NHS activity
 
Initial Review Rating
5.00 (2 ratings)
Benefit to WM population:
The West Midlands priorities that CliniTouch Vie can address are:
  • P2: Long Term Conditions: whole system, person centred approach
  • P4: Wellness, healthy aging and prevention of illness
  • P8: Digital Health
 
Our vision is for CliniTouch Vie to contribute towards and support the West Midlands wider vision to develop a worldwide reputation for delivering healthcare through digital technologies, proven to deliver sustainable improved outcomes and create wealth.  We have already demonstrated that it can deliver on all fronts with high risk COPD patients and is being adopted for Heart Failure, Diabetes, Cancer and Frailty pathways.  With an ageing population, often with co-morbidities, it can be used to support a more patient-centric approach to health care services in the region.
 
CliniTouch Vie supports health and wealth benefits as is a flexible, real-time remote monitoring solution, facilitating earlier discharge, prevent readmissions, reduce risk of future exacerbations and improve self-management through our inbuilt education resources.  CliniTouch Vie delivers a proactive approach to tackling symptoms, preventing exacerbations and slowing health deterioration, resulting in reduced NHS costs.  The system has an extensive data collection of medical, lifestyle, biometric and daily activity.
 
Targeting patients who are at risk or have multiple hospital admissions could significantly reduce the NHS costs to the region as well as freeing up clinic and nurse time to manage a wider caseload more efficiently. With a more collaborative, integrated, patient centred approach, utilising proven remote digital health, the West Midlands could see a potential reduction in admissions by 60%+.
 
CliniTouch Vie is a locked-down tablet, with integrated 3G for intensive monitoring, education and empowerment with integrated direct messaging and video support.  Our dynamic care plans and evidence-based algorithms enable automatic triage for healthcare teams. 
 
The tablet comes in an easy to carry case with the peripherals and can be handed to the patient at home, in clinic or upon discharge and is linked directly to the clinician web-based management portal.  Data within CliniTouch Vie tablet is stored securely within the cloud and hosted on the N3.  This makes CliniTouch Vie easy to scale due to its low technology and estates requirement, whilst delivering a high quality clinical service.
Current and planned activity: 
Current:
Spirit Digital is part of Spirit Health Group and can provide one of the most comprehensive range of solutions to support patients of all ages, IT capabilities & levels of disease severity across a wide range of conditions e.g. respiratory, cardiovascular, diabetes, cancer, frailty.
 
Spirit is establishing research collaborations with academic institutions around evidence generation for AI and machine learning. This includes collaboration on a bid to the European Space Agency to further develop the technology using satellite data.

Planned:
Spirit Digital seeks WMAHSN support ta assist with introductions and marketing of CliniTouch Vie to local CCGs. 
 
Our planned NHS engagement activity programme for the next 12 months will be through a variety of channels:
  • Direct engagement with CCGs and community Trusts
  • Application to Digital Accelerator programme
  • Case study development & sharing
  • Presentations at national conferences
  • Creating user (clinicians & patients) video footage to share with CCGs
What is the intellectual property status of your innovation?:
We hold the IP for the technology and digital health algorithms.  We collaborate with Midlands based businesses, healthcare providers and universities and retain all IP for products and services.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
2
Read more
Hide details
Emma-Jane Roberts 21/06/2018 - 11:25 Publish Login or Register to post comments
5
1
Votes
1
2
3
4
5
6
-99999
Read by QxMD, Institutional Edition (#2896)
Innovation 'Elevator Pitch':
QxMD is a company dedicated to creating point-of-care applications created by for healthcare professionals, with a global community of 1.9 million clinicians, medical students, scientists and researchers and are free to download and use at any time. 
Overview of Innovation:
Healthcare professionals need to stay up to date on the latest medical research and topic reviews to provide optimal care. Unfortunately, the process of content discovery is broken with research artificially compartmentalised by publishers and hidden behind countless institutional paywalls.

At QxMD, we believe that knowledge translation– the process by which new knowledge is incorporated into clinical practice – is an important and unsolved challenge for our health care system. Read uses smart algorithms to ensure that each and every user has a dedicated newsfeed of research that applies to their practice. 
With Read, Institutional Edition, organisations can seamlessly integrate their existing journal subscriptions and existing proxy service to provide a platform for their clinical staff to access content which matters to their individual practices. It is built with features designed to improve patient care and reduce costs. 

The Promoted Research feature is used by institutions who want to disseminate research that impacts areas of care the most within their organisation. For example, a Hospital with high rates of Sepsis can use this tool to promote guidelines that reduce Sepsis cases with higher guarantees their clinical staff will discover the research and apply it to the next patient. 

Librarians and Knowledge Managers can take advantage of smart analytics to understand which journal subscriptions are performing the best and worst and also which journals are most popular, which they don't subscribe to.

NHS Trusts are already adopting QxMD, with over 100,000 users in the UK alone. 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety
Benefit to NHS:
  • Better educatad and up-to-date staff, specific to their practice
  • Cost saving on journal subscription costs
  • Improved patient care
  • Challenges identified and tackled via the Promoted Research feature
  • Easy to discover and access research from any smart device
  • Links with OpenAthens for instant access to subscribed content. 
Initial Review Rating
2.60 (1 ratings)
Benefit to WM population:
  • Better educated healthcare professionals who can identify the latest research and apply it to patient care
  • Less chances of mis/under diagnosis, readmission or even death
  • Improved quality of care
Current and planned activity: 
  • Existing NHS Trust clients, including the largest Mental Health Trust in the UK
  • Continue to grow our userbase, which is already at 100,000 UK users, with the support of Trusts and other stakeholders. 
What is the intellectual property status of your innovation?:
  • We have designed and developed the platform entirely in-house. No white-labelling. A completely unique tool built by Healthcare Professionals for Healthcare Professionals. 
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Read more
Hide details
Jimmy Connoley 19/06/2018 - 11:56 Publish 1 comment
0
0
Votes
1
2
3
4
5
6
-99999
Sleep & Hypertension Diagnostic Service – S-Med offers a complete Sleep Apnoea and Hypertension Diagnostic service for GP’s (#2528)
Innovation 'Elevator Pitch':
Currently, a GP refers Obstructive Sleep Apnoea patients to an NHS Specialised Sleep Centre. Averaging 24 wks & 3-5 hospital visits before the Patient starts treatment.
Now, a GP with SOMNOtouch can receive results in 48-72Hours (3days vs. 6Mths)
Overview of Innovation:
Currently
The vast majority of patients with Obstructive Sleep Apnoea (OSA) are referred by their GP to a Specialised Sleep Centre at an NHS Hospital with a Average waiting time 12 Weeks


Patients are initially seen by a Consultant or a Sleep Physiologist who would prescribe a Diagnostic Study to be performed either in hospital or at the patient’s home. Average waiting time 12 Weeks
The patient returns to have the sleep study done or to collect the monitor and then returns the device the next day. After a further waiting time of upto 6 Weeks the patient visits the hospital again to obtain the results of the sleep study and if Positive, to discuss treatment.
A letter is sent to the GP informing them of the results and if agreed, a prescription is issued by the GP for the recommended therapy this may also take an average of 6 Weeks to arrive.
 This is prior to any treatment being administered such as a CPAP where if used they attend annually to check on compliance and progress.
 
This 6 month process is dramatically reduced by the S-Med Service to just a few days before an intervention can be delivered.


Now
The GP fits SOMNOtouch, a Combined OSA/Hypertension Monitoring Device to the patient, after 24 hours they return to the GP practice where the device is removed and the GP uploads the data from the device to a secure NHS Digital Cloud Server.
SOMNOtouch NIBP - Five devices in One
Video link: http://www.s-med.co.uk/Products#nav-product-86
 
S-Med Ltd’s Qualified and Registered Physiologists interprets the study and provides a recommendation for further treatment or investigation within 24 to 48 hours to the GP surgery. (All analysis and interpretations are supervised by a senior Consultant).
 
The report is sent to the GP who would then provide a prescription for the relevant therapy to be provided.
 
Thus within 48 to 72 hours a patient can be treated or directed for additional investigations or treatment before their condition deteriorates.

 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Advanced diagnostics, genomics and precision medicine / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Faster response times and time to providing treatment from an average time from referral to treatment of 6 months (24 weeks) down to 4 to 5 days (1 week). With the added benefit if there are more critical underlying conditions then these may be picked up and dealt with quickly
 
Reduction in costs of patients being referred to NHS sleep centres thus less calls and pressure on such specialist clinics e.g.:
 
Reimbursement Tariffs for OSA and Hypertension
Current reimbursement guidelines from the Department of Health are:
  • For Ambulatory Sleep Diagnostic Study: ￡391.00
  • For 24-Hour NIBP Study: ￡268.00 (UCL NHS Foundation Trust, there is no NHS tariff)
  • For 24-Hour ECG Study: Recording - ￡268.00 plus Analysis ￡215.00 (UCL NHS Foundation Trust, there is no NHS tariff)
 
Cost Savings Calculation
Assuming the following:
  1. Adult Population of the England is Approx. 45 million
  2. BLF figure show approx. 10% of population suffers from OSA = 4.5 million
  3. DH figures show that approx. 30% of adult population has Hypertension = 13.5 million
  4. Public Health England shows that 1.3 million people have Atrial Fibrillation
 
The cost of referring 1% of the above population to hospital annually, will cost approximately:
  1. OSA – 45,000 ￡32 million per year.
  2. Hypertension – 135,000 ￡79 million per year
  3. AF – 13,000 ￡10.5 million per year
 
Total cost of £121.5 million
Cost of S-Med Service - £38.6 million
Savings to NHS = £83 million per year.
 
Aside from OSA, this equipment can be used for chronic heart conditions studies as well as more longitudinal studies adding a wealth of data for clinicians to inform them of patient’s conditions at work, rest and play without the equipment being intrusive and disturbing as current cuff based systems thereby removing the abnormal results they can provide. Thus, this equipment may also be of benefit to clinical trial units or during treatment to monitor the physiological effects experienced by patients undergoing a drug or other clinical interventions. 
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
In addition to patients getting a faster diagnosis, it will reduce the burdens on NHS Trusts not only from the reduction on 1st line referrals to hospitals, but from patients conditions deteriorating, or suffering economic or social problems waiting 6 months for a diagnosis and treatment to be considered.

North West Innovation Agency (AHSN) will be conducting a pilot which will monitor 75 patients via a number of GP’s Practices. Results should be available by the End of February 2018.
As a West Midlands based company we would welcome an opportunity to work with NHS Trusts and CCG’s within the region to help us grow this service within the UK for the NHS and to increase our team to service and facilitate such requirements.  
Current and planned activity: 
Current NHS engagement
  • Embarking on a NIA application with North West Innovation Agency
  • Submitted an application into the ITP based on experience and adoption within the NWIA area.
  • Considering a NIHR project following a meeting at AHSN meeting - Speaking with West Midlands NIHR/CRN
Requested NHS engagement
  • Procurement / Adoption of: -  Would welcome assistance to gain greater Adoption by Trusts and CCGs within the West Midlands
     
  • Evaluation / Validation / Clinical Trial – Interested in trials for use of our ambulatory equipment (SOMNOtouch) within new clinical areas to show its versatility and extend its clinical use to provide validated evidence within in these new areas.
     
  • Project Assistance – S-Med is interested in locating potential clinical / academic collaborators to engage in their current work and to explore other clinical applications of their technology.
What is the intellectual property status of your innovation?:
Device IP held by SOMNOmedics Germany. Clinical diagnostic and reporting service is owned by S-Med Ltd.
Reg. CE0494
We have obtained IGSoC Level 2 (ODS Code: 8JP12)
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
3
Read more
Hide details
Selwyn Sher 03/10/2017 - 12:27 Publish Login or Register to post comments
0
0
Votes
1
2
3
4
5
6
-99999
Risk Tracker: Outcome Measurement in Preventative Services (#2475)
Innovation 'Elevator Pitch':
Sometimes it’s hard to prove impact. Risk Tracker helps organisations providing preventative services to record their work & demonstrate success. Provided free for anyone to use (under open license) Risk Tracker is for use on desktop & mobile devices
Overview of Innovation:
Risk Tracker is a powerful tool for managing clients and demonstrating outcomes. Designed to record information without getting in the way of the service you provide, it requires collection of a minimal amount of information from clients, but provides you with the flexibility to customise.
 
One of the key challenges for organisations who provide preventative services is connecting your clients’ progress with the complex range of National Outcome Frameworks. Inside Outcomes continuously maintains the policy environment to ensure that your reports will always reflect the most recent National Outcome Frameworks and, as the Frameworks evolve, we keep you up to date with the impact this will have on your day-to-day operation.
 
We have collated a database of issues that are common to preventative services. The system has been designed to support care navigation services by providing a quick tool to record client notes, measure outcomes and store files.
 
The Inside Outcomes Risk Tracker tool helps organisations to:
  • Record the common issues that clients present to services
  • Measure changes in those issues over time
  • Demonstrate the impact organisations have had in an evidence based way
  • Measure the impact organisations have had against National Outcome Frameworks
We have created a series of custom Risk Maps that reflect the issues clients commonly report, and aligned them with the public health life course. These Risk Maps cover diverse issues such as financial planning, housing and wellbeing, because we know the complexity of individual circumstances has an impact on your ability to provide services.

Our Risk Maps cover: We are also able to tailor risk maps to reflect service specific needs such as:-  
We also provide the facility to run anonymised open data reports that highlight social need in a particular area. Because we used a standardised format for recording the issues that people present we can aggregate data across multiple agencies to create a powerful, live commissioning tool.
 
We provide Risk Tracker free for anyone to use. We provide it under an open license so that you can run it in any way you want or even adapt the code for your own uses. You can access the code repository on our Github site. You can access the Risk Tracker manual here.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Health is influenced by a range of social, environmental and economic factors which are beyond the remit of the health sector.
 
Health services, social care and housing are all focused on delivering better outcomes at lower cost to public purse and finding ways of improving the effectiveness and better understanding the value of preventative services.
 
Risk Tracker measures the impact of organisations against national outcome frameworks, supporting them to translate the things they do into the outcomes that commissioning bodies are measured against.
 
Commissioners need to identify what services are required to deliver improvements in the prevention, diagnosis and treatment of physical and mental illness in their local population, Risk Tracker provides important data to identify top priorities and opportunities for transformation.
 
It helps commissioners to identify sub groups within their population and consider service requirements across the system, creating the person-centred services patients want and need.
 
Risk Tracker is a useful tool for analysing population data and identifying those who would gain most from the services and interventions being considered, commissioners then use this information to plan, deliver and monitor services for their local population.
 
When contracting for services, commissioners are looking for positive social outcomes, which have a lasting impact with benefits for patients that can be clearly demonstrated.
 
With Risk Tracker, information is used to improve services and influence commissioning decisions. Through recording client issues in a common format Risk Tracker allows the outcomes from disparate services to be compared and contrasted. For example, the cross over in issues that the clients present to substance misuse services, mental health services and housing associations mean that data can be aggregated together.

As all data is stored in a single, secure, compartmentalised system we can create aggregated, anonymised maps of social need. The live data that can be produced records social need and is an essential tool in commissioning services against evidenced social need.
 
Investing in prevention and better health outcomes can be part of the solution to the challenges of increasing levels of need along with shrinking budgets. Effective preventative interventions can reduce health and social care costs and the need for welfare benefits. Better health can also enhance resilience, employment and social outcomes.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Risk Tracker helps commissioners to plan services which meet national standards and local ambitions, by combining knowledge of existing service performance and population needs.
 
Commissioners traditionally do not have access to live local data. Having the ability to extract accurate data on health and wellbeing needs for a particular area supports a flexible approach to commissioning against need.
 
The methodology that underpins our system encourages services to carry out a whole person assessment.  This means exploring the range of issues that might be present in an individual’s life. Through identifying a range of interdependent issues, services can integrate how they work around an individual and improve their outcomes.
 
An important component of planning for transformation is recognising where services may
need to be decommissioned. Risk Tracker can help to identify where less effective approaches to service delivery are to be found. With a good understanding of how a service is currently operating commissioners can identify potential opportunities for innovation and improvement.
 
With Risk Tracker commissioners can develop service specifications that focus on paying for services which produce improved outcomes for their patients, rather than reimbursing providers for activity.
 
Risk Tracker will provide commissioners with the information they need to develop a vision of future service provision that will improve the health & wellbeing of individuals and communities in the West Midlands.
 
We provide Risk Tracker free for anyone to use. We provide it under an open license so that you can run it in any way you want or even adapt the code for your own uses. You can access the code repository on our Github site. You can access the Risk Tracker manual here.
Current and planned activity: 
Risk Tracker is a cloud based system & is constantly going through development as services identify new functions. We are currently exploring developing risk maps to support refugees & asylum seekers, people with disabilities, carers & suicide prevention.

Our next significant software release will incorporate individual access to records & the ability for clients to move their records from one agency to another. We believe that a person-centred approach to improving health & wellbeing requires the ability for individuals to manage their own records.
 
We would like WMAHSN to help to scale up Risk Tracker across the WM region. It is provided free of charge under an open license & users can run it in any way they want, even adapt the code for their own uses. By using WMAHSN’s network to promote this opportunity, WM commissioners can develop service specifications that focus on paying for services which produce improved outcomes for patients rather than reimbursing providers for activity.
What is the intellectual property status of your innovation?:
Inside Outcomes own the full IP for the product but release it for use under an open source license. 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
The Risk Tracker system has been built to be delpoyed at scale. The system can manage an unlimited number of organisations, and projects within organisations. The platform the system is built on is designed to dynamically utilise server capacity in line with the number of organsations using it. 
Measures:
The prinicple outcome we are aiming for is to be able to produce live data on social need for an area. 
Adoption target:
We are looking at opportunities to support neighbourhood working in line with strategic objectives of the West Midlands Combined Authority. The Risk Tracker system has been designed to set a basis for metrics in disaparate organisations and be used to integrate services using a common format of data collection. 
Read more
Hide details
Darren Wright 05/09/2017 - 15:35 Detailed Submission Login or Register to post comments
0
0
Votes
1
2
3
4
5
6
-99999
InterCare® - a digital solution to help the NHS, local authorities and care sector look after the people that depend on them. (#2441)
Innovation 'Elevator Pitch':
InterCare® enables digital health monitoring, self-care support, video consultations and social messaging - securely connecting patients with clinicians, care providers and family.
Overview of Innovation:
InterCare® is designed to make digital healthcare more accessible – with intuitive healthcare technology for elderly people, vulnerable adults, as well as patients who are more tech-savvy.

 
InterCare® takes a new approach to telehealth – integrating vital signs monitoring, self-care support, video calling and secure messaging in an accessible format. 

The intuitive digital platform and easy-to-use controls are designed to make healthcare technology accessible to all – including elderly people and vulnerable adults.

This versatile solution keeps patients in touch with everyone in their health and wellbeing network – clinicians, carers and family.  Proven in an NHS setting to reduce home visits and emergency hospital admissions, whilst significantly improving patients' health and wellbeing. 

Patients access the platform via InterCare® TV or InterCare® Mobile. A patient's own television can be InterCare®-enabled with a HDMI stick, webcam and user-friendly, large-scale keyboard controls.  This brings accessible technology to a broad range of patients, including the elderly, vulnerable, those who need support with chronic conditions and rehabilitation.

Patients can digitally track vital signs, such as blood pressure and oxygen levels – with alerts when these fall outside pre-set parameters, directing patients to their self-care action plan and ‘virtual’ consultations with their healthcare team when needed.  Empowering long-term-condition patients to take a proactive role in the management of health conditions, providing added reassurance, improving outcomes and reducing NHS costs.

InterCare® digitally connects patients with their professional and personal support network via secure messaging and video calls.

Clinicians and other health and care professionals can securely access the system via InterCare® Web or the InterCare® Mobile app. Family members can connect via InterCare® Web.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
InterCare® is a digital healthcare technology that enables NHS professionals, carers and family to be connected to a central user, in their home or assisted living facility.

InterCare® delivers health-data monitoring and alerts, video consultations, multi-disciplinary team messaging, self-care video content, health questionnaires and more, through a TV or mobile interface.  InterCare® TV makes digital healthcare technology accessible to a broad range of patients, including the elderly, vulnerable and others who need support with chronic long-term conditions. 

The NHS benefits from connected, efficient care of long-term-condition patients, in their own homes.  Empowered patients take a proactive role in the management of their health conditions, reducing anxiety and improving outcomes.  The resulting reduction in the numbers of home visits, appointments, A&E attendances and unplanned admissions, delivers significant savings for the NHS across some of the costliest population cohorts.

A recently completed 12-month NHS deployment, connected patients with severe COPD to their community respiratory nurses.  InterCare® TV was installed in the patient’s own houses in South Tyneside and a wide range of functionality utilised.  Wider care and family networks were also connected where appropriate and the following improvements in condition management and outcomes were reported:
  • 37% reduction in unplanned admissions
  • 33% reduction in home visits
  • 43% reduction in follow-up outpatient visits
  • 50% COPD users showed improved cat scores
  • 62% of patients with reduced anxiety scores
  • 43% of patients with reduced depression scores
  • 100% usability reported by patients
 
The cost effectiveness of the InterCare solution demonstrated by these reductions is significant, when set against the standard NHS costs for patient interventions in either community, primary or secondary care.
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
Could do with advice on filling this section
Current and planned activity: 
We have launched a new website which details the use of InterCare® in an NHS environment and carries case studies.  We are seeking to hold meetings with CCGs/ACOs/STPs where an expression of interest in utilising technology to assist in the management of long term condition patients in their own homes or in assisted living environments.  We have the potential agreement in three locations to work with clinicians who see the benefit of our InterCare® solution but do not have funding available to them. We are seeking funding in order to move forward with those pilots.
What is the intellectual property status of your innovation?:
Wholly owned by Nimbus Medical.
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
3
Rejection Reason:
Unable to contact innovator to clarify aspects of the submission
Read more
Hide details
Mark Pedder 04/08/2017 - 14:57 Rejected Login or Register to post comments
0
0
Votes

Referral Tool: Identify local referral agencies (#2368)
Innovation 'Elevator Pitch':
Crowdsourcing the most appropriate referrals to improve pathways and promote integration. Using whole person assessment to enable to agencies to work together more efficiently around an individual. 
Overview of Innovation:
Referral Tool app has been designed to quickly identify local organisations that you can refer clients to. It’s been created to complement any data system you use, entirely focusing on improving the quality of referrals.

The system works through carrying out a brief whole person assessment. This involves talking to the client and trying to assess the full range of issues that they are looking for help and support with. Using our simple Risk Maps these issues can be quickly recorded.

Both clients and workers are presented with a succinct list of appropriate referral agencies for the issues identified. Through creating a holistic approach to providing help and support agencies can tackle those complex issues that require joint working, therefore, improving outcomes. 

We have created this to be used across a local area with all of the organisations using it to crowdsource the most effective agencies to help resolve problems. As agencies understand the issues they are best placed to resolve they can manage which clients are referred to them. This dispersed system of management means no one agency is required to keep data up to date. As a result, this is a sustainable system created to reduce central management costs. 

Every agency can customise the system to reflect the sort of issues that their clients present. Which means the assessment process is simplified to focus on the things that are most important to the person in front of you and can be carried out in a matter of minutes. 

Designed to focus on services such as social prescription or community navigation, Referral Tool can be easily used by any agency that carries out face to face client work. 

As all issues raised are recorded in the same format, Referral Tool also generates open data reports to identify patterns of social need in an area. This can be used to inform commissioners on where the most pressing commissioning needs are. 

Referral Tool is released under an Open License for anyone to use in any way that they want.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Person centred care
Benefit to NHS:
As many people present to service with complex issues it is rare that a single agency can resolve all issues. Where issues are interdependent on each other then it is essential that agencies work together coherently to support an individual. Referral Tool provides an easy method  to identify relevant local agencies and how to make a referral.

This avoids many of the problems of service directories as there isn't a need to keep the referral data up to date, this is manged by agencies. It also does not require someone looking for referral agencies to second guess how to search for agencies 

As all data is collected in the same format Referral Tool can also produce geographical maps of need to demonstrate where commissioning priorities should be set. 
Initial Review Rating
3.40 (1 ratings)
Benefit to WM population:
The WM population benefit on a number of levels. More integrated services mean that they do not have to seek help from a wide range of sevices. A seamless referral process is less likely to discourage people from taking up services they are offered. 

As Referral Tool can generate live data on local need then commissioners have an evidence base for how they can target services to address local need. 
Current and planned activity: 
We are currently using Referral Tool across Sandwell but this is voluntary sector promoted activity rather than via the NHS. 
What is the intellectual property status of your innovation?:
We own the intellectual property of our Referral Tool product but make it available to anyone under an open license.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
This tool can be easily scaled across the West Midlands region. We are in the process of rolling it out across Sandwelll. The Sandwell roll out has been fully funded and can be used by anyone in that area. For the best outcomes the tool functions in local authority areas in order to ensure that referrals and pathways are most appropriate to clients and patients. 
Measures:
We are guaging success by measuring penetration within face to face services where the tool is being implemented. This can be easily measured through the way the tool creates open data maps of social need in a given area. 
Adoption target:
We are looking to implement the Referral Tool in each local authority area in the West Midlands. 
Read more
Hide details
Darren Wright 16/05/2017 - 15:49 Detailed Submission Login or Register to post comments
0
0
Votes
1
2
3
4
5
6
-99999
MIRA – Evidence based video-games for rehabilitation and physiotherapy (#2329)
Innovation 'Elevator Pitch':
MIRA is a software application designed to make physiotherapy fun and convenient for patients in need of rehabilitation. It turns physical exercises into video-games and uses Microsoft Kinect to track and assess patient treatment compliance.
 
Overview of Innovation:
Physiotherapy and rehabilitation can be a long, difficult and sometimes painful process. Treatment plans can be cumbersome and a slow recovery can be disempowering for patients. 70% of patients do not adhere to home exercises, which increases the total time needed for recovery, leading to higher costs for the healthcare sector.

MIRA displays these exercises as video-games and asks patients to complete the recommended movements to progress through each game level. As a result, patients are playing, while at the same time actually recovering. The patient’s performance data is also tracked, storing all the repetitions, improvements or issues for the therapists to adapt the treatment accordingly. As each patient and their treatment require careful planning, MIRA is designed as a tool for the therapists, to enable specialists to customise the treatment for each individual. Our innovative software can be tailored to the patient’s condition, needs and goals (stroke, falls prevention, MSK disorders etc.), using off-the shelf hardware (laptop/PC and motion sensor).

The software application is registered as a Class I Medical Device in Europe (CE Mark) and can be installed in any clinical environments where patients go for their regular treatment sessions, as well as at home where patients can be remotely monitored by their therapists. This allows the patient to exercises at home under the remote supervision of a healthcare provider. Furthermore, MIRA reduces costs by supplementing staff and reducing waiting times, as well as by decreasing the necessary number of clinic visits and the travel costs associated to them.

The system runs on Windows PCs, using Microsoft Kinect, a mainstream motion capture camera, to engage and track patients throughout their treatment.

MIRA Rehab has 14 UK institutions and another 44 worldwide, helping 600 patients monthly.  The youngest patient to have ever used the system was 3 years old, while the oldest is 102. MIRA was recently featured on BBC, as well as on TED.com in 2015.












www.mirarehab.com

Video links:
MIRA – Play your way to recovery
MIRA – Helping older people regain their mobility
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Person centred care
Benefit to NHS:
The primary benefits to NHS provided by using MIRA are mostly related to health outcomes, efficiency & cost effectiveness. Thus, MIRA can:
  • Supplement staff shortage and reduce waiting times, by enabling more patients to be treated at the same time at the clinic as well as remotely supervised at home
  • Reduce recovery time for a large group of patients by increasing motivation for the adherence to treatment through an interactive and engaging exergaming tool
  • Reduce costs associated to travel by decreasing the necessary number of visits to the clinic
  • Prevent further injury or surgery and thus reduce important costs associated to further hospitalisations and treatment caused by lack of compliance to the initial treatment
 
Quotes from NHS clients
"The [MIRA] concept is that it will replace me, as the clinician, or the therapist who is going to do the exercises with the patient. Not for all of the time, but for a part of the time. So it will supplement what we do and it will also improve patient care because patients will do it better based on the principles of gamification. When I describe it to people, people just go Wow! If this continues, it will change the way modern medicine is practiced"
Mr Bibhas Roy,
Shoulder and Elbow Surgeon, Central Manchester NHS Foundation Trust 
               
“There is huge potential. I give a lot of talks to older people and they are very interested…There is a great need there. You can have a lot of patients using the exergames at home with the physio reviewing and keeping an eye. With the data that is remotely sent to the clinic you can very easily see if individuals are complying, improving, and if they are not improving whether they need a visit.
Emma Stanmore,
Lecturer in Nursing, The University of Manchester
 
“Many individuals over the age of 65 haven’t played computer games before, but those who have been helping us test the technology have given us very positive feedback.”
Emma Stanmore,
Lecturer in Nursing, The University of Manchester
 
 “MIRA is an innovative product that could alter the way therapy is delivered to patients in the future. It has the potential for patients to be more active in their rehabilitation, which should result in improved patient and service outcomes.”
Mark McGlinchey,
Clinical Specialist Physiotherapist, Guy’s & St. Thomas’ NHS Foundation Trust
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Benefits for WM
  • An innovative tool that offers the possibility to have a better supervision of their patients, better medical outcomes and a more competitive practice
  • Created based on the best available clinical evidence (ex. Falls prevention exercise package) and validated in clinical trials
  • Net average saving associated with the use of Exergames for falls prevention would be £1,202 per patient per year for one MIRA unit (Health Economic Report by JB Medical)
  • The clinic can offer MIRA as a separate therapy service, developing a new business opportunity, improving treatment and physiotherapy services delivery (like reducing waiting times)
  • MIRA allows them to track patients’ compliance and progress at home
  • Reduce readmission and costs associated to further treatment and hospitalisation due to non-adherence to initial prescribed therapy (ex. Home exercises are more likely to be done if patients are being checked and if they have an engaging tool.
  • Specific therapy plans for patients can be prescribed from any location, and  it offers a suit of customisable exercises and games that therapist can easily tailor as they see fit for their patients
  • Possibility to monitor and engage more patients at the same time
  • Based on this modern instrument with its data gathering feature, therapists can access new research opportunities, important movement data and statistics that were not easily available before
  • Patient data is safe – data protection and security regulations have been carefully implemented to ensure best protection and security measures required have been implemented
    ​
Benefits for its population
  • An attractive environment through gamification engages patients to perform the prescribed exercises and comply with their treatment avoiding further complications and reducing recovery time
  • A new, easy and fun way to interact with rehabilitation or therapy
  • Patients can continue exercising in between clinic sessions being guided and supervised by a medical specialist, keeping a closer contact with the clinicians
  • Based on occupational therapy MIRA distracts the patients’ suffering and focus on pain while exercising
  • Increase the quality of patients’ life and of their families
  • When they cannot attend the therapy sessions MIRA is an efficient tool and fast way to perform the prescribed treatment plans at home
Current and planned activity: 
Current NHS Engagement:
1. Central Manchester University Hospitals NHS Foundation Trust (CMFT)
2. Guy's and St. Thomas' NHS Foundation Trust (GSTT)
3. Epsom and St Helier University Hospitals NHS Trust (ESTH)
 
Planned Activities/Upcoming:
Five other NHS organisations are in the process of implementing MIRA in their treatment delivery;

MIRA is a platform created to support extensions with new packages targeting new types of rehabilitation (hand fine movements, aerobics, speech therapy, etc.). Thus, we are willing to engage with clinical partners for clinical input, studies and validation on the development of the new modules. 

(See attached NHS Engagement document for further details)
 
What is the intellectual property status of your innovation?:
No patent on product as it is a software product (trade secret). We have full copyright of the software and source code of the application.

We are in the process of registering the MIRA trademark.
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
3
Read more
Hide details
Cosmin Mihaiu 11/04/2017 - 15:53 Publish Login or Register to post comments
6
4
Votes
1
2
3
4
5
6
-99999
Monsenso's innovative mhealth solution improving mental health care (#2296)
Innovation 'Elevator Pitch':
Monsenso is an innovation leader within mHealth for mental health, providing a Class 1 CE-marked medical application for data collection and sharing, to support better mental health at lower costs.
Overview of Innovation:
Monsenso is a solution that enables easy development and deployment of user-centred monitoring and feedback systems, which are tailored to a specific mental health problem, such as bipolar disorder. The system is configurable, which enables accommodation of clinical needs and easy implementation within clinical settings. The core of the system is to support a continuous monitoring and feedback loop that allow data to be sensed and entered by the individual, while the system then use this collected data to provide appropriate and situated feedback to the individual, as well as sharing data with a care provider and, if appropriate, a caregiver.


As illustrated in above figure, the Monsenso Solution provides individuals with a smartphone application, on which they perform daily self-assessments. Furthermore, the individual's’ physical condition can be monitored automatically through the embedded sensors in the smartphone. The system can detect behavioural changes through configured triggers and early warning signs to give individuals useful feedback.Furthermore, the app provides the individual with action plans for tackling certain situations that they might encounter.
All this information is visualised for the individual through graphs, and simultaneously synchronised in real time to a web portal for care providers, giving them the needed overview and information about their assigned individuals’ mental health. This way the care provider can channel efforts towards individuals who really need help and physical consultations. When the individual then comes in for a consultation, the care provider has a broad historical overview of the individual’s mental health over the past period, instead of relying on the individual to share this information.
 
The Monsenso Solution allows individuals to grant access to caregivers, to receive aggregated data regarding the individual through the app. This keeps caregivers informed remotely of the wellbeing of the individual, and enables them to provide input for both individuals and care providers. Not only does the solution keep the caregiver informed about the state of the individual, it also helps the caregiver cope in situations that might arise. 
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Return on Investment (£ Value): 
N/A
Return on Investment (Timescale): 
N/A
Ease of scalability: 
N/A
Read more
Hide details
Drew MacKenzie 29/03/2017 - 11:00 Archived Login or Register to post comments
0
0
Votes

Rally Round - more support for frail or vulnerable adults or people recovering from illnesses (#2242)
Innovation 'Elevator Pitch':
Rally Round helps frail and vulnerable adults to live well at home. It also helps patients recover from illnesses and other health challenges. See  www.rallyroundme.com
Overview of Innovation:
What Is It?
Rally Round is an easy to use secure social networking tool that allows family members, friends and carers to easily create and organise support for someone they care about.
 
Core Features
A support network account is created and other trusted family members, friends and carers are invited to join. Everyone adds support tasks that need doing, such as shopping, help with transport, socialising etc. Network members choose which tasks to help out with. 


Text and email alerts remind everyone what needs doing, who is doing what and when things need to be done. 
Important information can safely be shared with other members of the support network via the Noticeboard.


Rally Round can be offered to people in 3 ways:
 
Self Service: social media marketing and off line promotion drives local people to a bespoke Rally Round website landing page. From here people can create and build up support networks themselves.
 
Assisted Networks: NHS Staff (plus partner organisations and third sector organisations) refer people to Rally Round via an online referral dashboard. Referrals made instantly trigger an automatic email and phone based onboarding service provided and run by Rally Round.

Managed Networks:  NHS Staff (plus partner organisations and third sector organisations) are trained and supported to introduce Rally Round to relevant clients and/or families of clients. They do this via a managed networks login that allows networks to be created very efficiently. Staff who use this process are automatically assigned to be the coordinator of the networks they create. In this way they can build up the support network by issuing invitations to family members, friends or volunteers before leaving.  

Social Capital and Performance
 
Licence holders have access to a Data Dashboard. This lists all the networks associated with their licence together with key performance data e.g. number of helpers in each network, number of support tasks moving through a network and the resilience of each network as measured by the way in which support tasks are shared amongst network helpers. In essence the Data Dashboard provides a glimpse into people’s social capital. 









 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption
Benefit to NHS:
 Benefits to NHS organsiations:
  1. Strengthen prevention and self-care strategies
  2. Defer demand for GP and other primary care services
  3. Speed up discharges from community rehab / step-down facilities
  4. Support recovery of some MH clients 
  5. Defer or reduce volume and cost of carer breakdowns
Benefits to Local Authorities:
  1. Strengthen prevention and self-care strategies
  2. Defer demand for funded social care support
  3. Extend reablement support by utilisation of family members and friends
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
Benefits to vulnerable persons / patients / clients:
  1. Remain living well and independently in own home for longer and/or recover better
  2. Receive more practical and timely support from carers, friends and family members
  3. Reconnection with more friends and relatives
  4. Reduced loneliness and social isolation
  5. Improved quality of life
Benefits to carers, family members and friends
  1. Less 'burn-out' / more practical help on a day to day basis
  2. Enhanced ability to remain in or return to paid employment
  3. More time freed up for pursuit of own interests
  4. Ability to offer help, even if physically distant
  5. Peace of mind, through access to the dashboard information, that a loved one is getting timely support.
Current and planned activity: 
Several Local Authorities and third sector organisations already use Rally Round, including Essex County Council, Bradford MDC and Bolton Council. We are now keen to work with NHS organisations to explore the potential for Rally Round to be offered systematically to patients to help achieve a range of demand deferral, prevention, self-care, discharge and recovery goals. 
What is the intellectual property status of your innovation?:
Rally Round has been created by Health2Works Ltd. As such we own and control use of all software code.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
Simple
Read more
Hide details
Steve Pashley 17/01/2017 - 12:38 Publish 2 comments
6
2
Votes
1
2
3
4
5
6
-99999
Safe Mobile Care (SMC) - Enabling a more effective and efficient healthcare system (#2236)
Innovation 'Elevator Pitch':
SMC provides an innovative, integrated, digital platform solution that deliver better patient outcomes, greater self-management and delivers healthcare more efficiently. The system is highly configurable and customisable and deployable at scale.
Overview of Innovation:
SPS have created an open, future proofed digital platform that harnesses and integrates a range of mobile, communication and wearable technologies to pre-emptively and pro-actively support improved patient outcomes while enabling more efficient healthcare service delivery across primary, secondary and social care environments.
Our mobile health (mHealth), telemedicine and telecoaching solutions use familiar mobile and ‘cloud’ based technology. It has been proven to  support service redesign and deliver more efficient, patient centric healthcare that’s cost effective, simple to use and easy to implement at scale.
Our ‘open’ architecture and web based platform enables more holistic Long Term Condition management services by leveraging a range of technologies across mobile, tablet, text, video and voice to deliver a highly flexible solution for healthcare professionals and patients. Mobile health (mHealth) enhances patient outcomes by enabling clinicians to pro-actively and pre-emptively monitor patients remotely while also enabling the individual to better understand and manage their condition that results in improved patient outcomes, reduced visits to hospital and local GP’s Surgeries.
Our SMCTM solution can be customised to meet any Long Term Condition (LTC), co-morbidity or medical condition that an individual may suffer from. It can support one or multiple LTCs, as well as any other health or mental health condition where a question or vital sign measurement can be of benefit. To date core commissioning has been focused on supporting people who suffer from Heart Failure, Coronary Heart Disease, Hypertension, Chronic Obstructive Pulmonary Disease, Asthma and Diabetes, but we have also developed profiles to support Urinary Tract Infection, Falls Prevention, Dementia and Depression management, Cystic Fibrosis, Obesity and end of Life.
The SMCTM solution is deployed across multiple CCG’s and provider in the UK with over 10,000 patients benefiting from the system over the past 5 years. We have supported different operational and clinical pathways, including effective system deployment into patient homes and Care Home environments that can then enable pro-active and pre-emptive alerts to be raised with a Clinical care team.  Our technology and services have also been selected by a wide range of organisations including BT Health, Alere, Welch Allyn, MSD Commercial, Healthcare @Home to support new and existing service models in the field of telehealth.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Key deliverables achieved with SMCTM solution:
  • Facilitate early patient discharge and reduce bed days: Harrow CCG, 2014: achieved a 50% reduction in unplanned admissions and 63% bed day reduction to deliver an ROI of 159% and net savings of £3,444 per COPD and cardiac patients.
  • Improve prevention and early intervention:  Derbyshire Community Hospital, 2014: achieved a 68% reduction in unplanned admissions; 415 bed day reduction across 187 patients in a 6 month period with a net saving of c£100,000.
  • Improve service value and efficiency of service provider: Bristol CCG, 2013: within just 30days of the telehealth service starting the number of contacts reduced by 26% with an 18% reduction in face to face time and 40% reduction in telephone contacts
  • Sustain independent living and improve patient outcomes: Birmingham Community Health, 2014: Surveyed 312 patients with 86% of patients stating system helped them manage their condition; 84% more involved in their care; 90% happy to reduce the number of routine hospital visits.
     
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
SMC offers multiple benefits for patients:
  • Personalised care modules: supports an individual's care needs using the most relevant questionnaires, vital signs and content.
  • Embedded educational content: on demand video aids training, behaviour change, understanding and the confidence for patients to self-manage their condition.
  • Sustains independent living: the use of relevant, integrated and familiar technology empowers patients to better understand and manage their conditions at home.
  • Easy to use and "out of the box": use fo familiar smartphones and tablets with wireless peripherals; audio and multi-lingual options.
  • Remote access and support software: touchscreeen enabled device support over the phone.
  • Video tele-consultation: remote "face to face" clinical consultation to aid better clinical intervention.
  • Text messaging: enable cost effective self-care.
  • Better patient outcomes: improves quality of life, reduces anxiety and increases confidence.
Current and planned activity: 
The SMC solution is deployed across multiple CCG’s and provider in the UK with over 10,000 patients benefiting from the system over the past 5 years. We have supported different operational and clinical pathways, including effective system deployment into patient homes and Care Home environments that can then enable pro-active and pre-emptive alerts to be raised with a Clinical care team.   Our technology and services have also been selected by a wide range of organisations including BT Health, Alere, Welch Allyn, MSD Commercial, Healthcare @Home to support new and existing service models in the field of telehealth.
We have long standing partnerships with Somerset CCG, Cornwall Foundation Trust Rotherham NHS Foundation Trust, and Dudley CCG and have been awarded innovator partnership on two Test Beds, one in Surrey and one in Manchester (with MSD Commercial.)

We support other conditions and pathways: Cystic Fibrosis, Falls and UTI, Spina Bifida children, LTC6 and E5QD quality of life.
Return on Investment (£ Value): 
N/A
Return on Investment (Timescale): 
N/A
Ease of scalability: 
Simple
Read more
Hide details
Elisabeth Barbosa 12/01/2017 - 16:57 Publish Login or Register to post comments
0
0
Votes
1
2
3
4
5
6
-99999
Recap Health - Personalised Patient Education and Self Care Platform (#2231)
Innovation 'Elevator Pitch':
Recap Health enables NHS clinicians and social care professionals to efficiently deliver personalised, relevant, timely and up-to-date digital health and social care content (videos, leaflets, website pages etc) direct to selected patients/clients. 
Overview of Innovation:
                                  

Recap Health is a cloud hosted patient education and clinical information delivery application. It enables clinicians to quickly find and send relevant digital health content to their patients, helping patients to become better informed and better able to manage their own health effectively.

Clinicians
Clinicians select relevant digital content (videos, leaflets, web pages, third party apps, events etc ) from a library of pre-approved digital content. Content can be searched by health condition, age, language and media type etc. Content can also be packaged into pre-defined 'bundles' to facilitate speed of use. At the click of a button clinicians can send content to individual patients.

Clinicians can favourite content for future use. They also can see what content their peers use and they can see clinician and patient reviews and rating of content. 

Patients:
Patients with Recap Health accounts receive an email notification, alerting them to the arrival of new content. They login and see their personalised content (videos, leaflets, apps, website pages etc), in an attractive personalised webpage. As well as consuming the content, patients also can hide content, rate and provide feedback on their content and share it electronically with family and friends.

Organisations:
Recap Health records whether and when a patient has accessed their content which enables organisations to classify patients in relation to how 'activated'/engaged they are.

In future, organisations will be able to set a series of time or behaviour based rules associated with how patients relate to their content. Rules can trigger in-app messages, emails and or offers of live chats.  In this way Recap can become a platform for engaging with 'at risk' or newly motivated patients in a more proactive way.

In addition, short online surveys can be presented to individual patients to measure knowledge and motivation to self care, both pre and post accessing content. 

Recap Health has been developed in partnership with a Mental Health and Community Trust but we believe it can also be used also by Acute Trusts, Community Trusts, GP Federations and Local Authorities. It also can be a vehicle for health and social care economies that wish to foster clincial collaboration across professional and organisational boundaries, to achieve shared self-care and patient engagement objectives expressed in STPs, NMCs and/or digital roadmaps. 

 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
In general terms, by using Recap Health, NHS organisations can raise patients' health literacy levels and their ability to practice effective self-care. Clinicians also can extend their relationship with their patients beyond the boundaries of face-to-face encounters.  

More specifically, NHS organisations can realise some or all of the following benefits:

Cost Savings:
- Less demand as more knowledgeable patients become more motivated and better able to practice effective self care
- From the digital storage and electronic distribution of large volumes of patient information

Quality:
- Better version control of patient information and a tighter focus on the nature of the information itself
- Better relevance and timeliness of patient information sent to patients
- Access to ongoing patient feedback about the quality and relevance of information sent to them 
- Access to data reporting on which content is most popular, most used, most revisited etc.

Intelligence:
- Access to data identifying the extent that individual patients consume content, which allows patients to be stratified into activation cohorts 
- Audit trail ​of information interventions

Cultural:
- Makes collaboration across a health and social care economy more likely as clinicians from multiple organisations use Recap to communicate with 'shared' patients
- Empowers frontline or generalist staff as they gain the ability to find and distribute content traditionally distributed only by specialists (often after an appointment)
- Accelerates the 'media shift' trend away from traditional information leaflets towards short videos
- Supports the drive towards a paperless NHS 
Online Discussion Rating
5.00 (2 ratings)
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
By accepting electronic invitations to join Recap Health, patients in the West Midlands will:
  • have easy access to personalised, timely and accurate healthcare information 24/7 
  • have a much better opportunity to become more knowledgeable about their condition / healthcare situation and what appropriate self care strategies are
  • feel more connected to the clinicians and NHS organisations that serve them
Current and planned activity: 
Recap Health is being trialled at scale by a Community and Mental Health Trust in another region. 

We plan to start marketing Recap Health across the UK in mid March 2017. Our preference though is to work with WMAHSN to find one or more suitable early customers and to work closely together to:

1) better understand the value proposition and associated technical and legal risks; 
2) further develop the product to optimise value
3) determine appropriate price points and licencing terms
4) explore the potential for sourcing validated 3rd party content at scale to supplement locally generated content 
5) develop appropriate implementation support services informed by the experience of early adopters.

On the product side we have a highly detailed and fully costed technical roadmap for developing out new features and improving existing usability, features and design. We are pursuing this on an ongoing basis, with pace dictated by when cash becomes available to us.


 
What is the intellectual property status of your innovation?:
Recap Health has been created by Health2Works Ltd. As such we own and control use of all software code. 
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
2 years
Ease of scalability: 
2
Regional Scalability:
Recap Health can scale very easily, both in terms of numbers of users and distinct implementations. For example a version for a new customer can technically be cloned and deployed with a few hours.
 
There will however be technical work for H2W to do to serve a multi-organisation customer. Either we will need to deploy separate instances of Recap Health and retrospectively connect them together or we will need to do this work prior to commencing deployments. The work involves determining identities and permissions for organisations, job roles and shared patients and associating these with bespoke views of the content library.
 
Implementation for customers is more time consuming than technical deployment. Customers will need to develop and resource an implementation plan, focused on 1) content curation and review, 2) service roll-out, 3) product awareness sessions, 4) clinician account generation processes etc. We plan to offer an implementation support service at cost to new customers.

 
Measures:
We believe Recap Health has the potential to help NHS organisations realise at least 12 tangible benefits associated with Cost Savings, Quality Improvement, Data Acquisition and Culture Change. These benefits are already listed in the Benefits to NHS section of this submission.
 
The measures associated with these potential benefits will need to be identified and agreed with customers and ideally a local University research unit. We have a good relationship with Keele University (our local University) and we are in discussion with them about the possibility of Keele offering independent research support to new Recap Health customers in the West Midlands.
Adoption target:
Our aim is to have 4 NHS organisations as customers in the next 12 months, with one being multi-organisation in nature.

We prefer to focus entirely on the WM region, however we plan to start UK wide marketing activity in mid March, unless a strong focus on West Midlands looks like it will meet our needs.
Rejection Reason:
​The panel felt that while Recap Health was a strong and versatile proposal, it didn’t sufficiently focus on diabetes prevention. There were also concerns that the need for professionals to prescribe specific bundles would make the implementation phase dependent on significant clinicians engagement activity before any benefits could be realised. On that basis, the panel decided not to recommend the product for this specific challenge.
Read more
Hide details
Steve Pashley 11/01/2017 - 15:59 Rejected 3 comments
0
0
Votes

Kemuri Wellbeing Monitor (#2230)
Innovation 'Elevator Pitch':
Protect people with dementia from unattended falls, dehydration, malnutrition and hypothermia by hourly checking patterns of normal activities in their kitchens. 
Overview of Innovation:
Many older people want to live independently for as long as possible, causing anxiety for family and friends.  They are often in denial of their declining capacity, proud and won’t wear pendants.  With impaired cognition, many suffer from unattended falls, dehydration, malnutrition or hypothermia.  They are admitted to hospital needing longer treatment for poorer health outcomes and greater risk of transfer into a care home. 

To make sure that service users are moving around as normal, drinking, eating and warm, Kemuri checks every hour.  It alerts families and carers of important changes and provides valuable details for guiding action.  Peace of mind results in better outcomes and reduced costs for everybody.

Kemuri does not stigmatise because it looks a familiar Power Socket to the service user.  There’s nothing to remember and people continue with normal activities such as boiling kettles and heating food in microwaves or other electrical equipment.


KemuriSense® mains Smart Power Sockets continuously monitor motion, power usage, temperature and humidity and send data via GSM mobile phone signals to the Internet.  Mains power loss is automatically reported whilst it continues to report other sensor readings.  

The Wellbeing Monitor App informs families and carers of older vulnerable people who:
  • Want to live independently
  • Reject or forget pendant alarms
  • Deny declining capacity
  • Show symptoms of dementia
  • Remove things they don’t understand
  • Need daily monitoring 


Predictive analytics check every hour for changes to patterns of motion and power usage.  If there are many changes, then alerts may be sent to families, carers or 24/7 response centres.

As stated by a Commissioning Manager at a County Council, “ ... this is a unique product ….  I think there’s potential here for both self funder and LA funding as a potential option that fills a gap that conventional telecare does not.”
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health
Benefit to NHS:
Dementia is increasing in the population. Kemuri is a tool for stabilising the wellbeing of older people living alone who are declining in their ability to undertake Activities of Daily Living. Better wellbeing means healthier people, better health outcomes & more efficient use of NHS resources. Institute of Ageing research shows a range of pathways that people take before they are unable to live independently.


Early intervention is proven to reduce costs significantly. Kemuri should be deployed as soon as people are showing early symptoms of dementia. With loss in mobility, falls are inevitable: half those 80+ fall at least once p.a. Falls cost the NHS £2bn p.a. People with dementia tend to forget their pendant alarms/wearable telecare devices. If unable to call for help they may suffer for days before discovery & admission to A&E with medical complications. Kemuri’s hourly analysis of patterns of motion power usage automatically alerts to the risk of unattended falls.

In comparison pendant alarms are ineffective with early stage dementia. Out of 1.6m issued 32% are never worn & only 8% are worn all the time as prescribed. 500,000 unworn pendant alarms waste as much as £80m p.a. Kemuri continuously monitors motion, learns patterns of activity without any cognitive input from the service user.


A value to the NHS of early A&E admission into hospital is better health outcomes & more people discharged back to independent living on average after 12.3 days (discharge to residential care on average 31.7 days, 2.5 times longer).



£5000 could be re-allocated for each episode avoiding discharge to a care home. Unattended falls longer than 24 hours result in stabilisation time, longer treatment & delayed transfers of care. Kemuri preventive telecare with a wellbeing monitor & daily attention will also help to minimise the number of patients suffering the effects of hypothermia, dehydration & malnutrition.
  • Cold homes cost the NHS in England more than £1.36bn p.a.
  • Dehydration complications include low blood pressure, weakness, dizziness, increased risk of falls, & pressure sores
  • Malnutrition costs the NHS £7bn p.a. Risk (in 2010) was 28% in patients < 60 years, 32% 60-79 years & 44% if > 80 years
Kemuri could be funded by the NHS for a few weeks after discharge on the grounds that people admitted in a healthier state are less complex to treat, have improved health outcomes & are less likely to be readmitted, with the ongoing service funded by Social Services or self-funders.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
West Midlands has a population of 5.6 million people covering an area of more than 5,000 square miles.  It is a region full of contrasts and diversity.  It includes the second largest urban area in the country (Birmingham, Solihull and the Black Country) yet over 80% of the area is rural.  It is the second most ethnically diverse region in the country after London.  There are probably 40,000 older people who might be suitable for passive wellbeing monitoring.  Many of these are admitted to hospital and may not be able to return to their own homes. 

Older people are at the focus of Kemuri wellbeing monitoring.  Hourly and daily pattern analysis reduces risk and extends the period that they can continue to live independently at home.  Everybody has access to information that reduces the risk of unattended falls, dehydration, malnutrition and hypothermia.  Alerts are automatic without older people having to change their life style.  A familiar power socket is not stigmatising or intrusive.  There are no wearable devices to remember or unfamiliar sensors to be discarded.  Discharge from hospital could be accelerated with a KemuriSense Power Socket pre-installed.

Families and carers use the Wellbeing App for peace of mind.  At any time of day, from anywhere in the World, people can view the changes to patterns of behaviour.  There’s an option to receive alerts after more changes than usual.  They can enquire about wellbeing with full knowledge of the predictive analysis and decide on appropriate action. Some of the tragic outcomes of unattended falls are avoidable with hourly monitoring.  Additionally, it’s possible to confirm that domiciliary carers have provided drinks and meals at the time they were ordered.

Service organisations benefit from accurate data.  Sheltered housing wardens, domiciliary care providers and alarm response centres have full access to the Wellbeing Monitor and can prioritise their care calls.  Kemuri is efficient to deploy.  The portable model is operational in ten seconds with no skill required.  The fixed model can be installed and tested within 15 minutes.  There are no rules to enter because the system learns patterns of activity.  Alerts are automatically sent to response centres or users of the app.  
Current and planned activity: 
Manufacturing batches of 100 units for trials/sales to housing associations/telecare service providers. First trials are in sheltered accommodation in County Durham in conjunction with Durham University (part of EU funded Erasmus+ project)

Controlled clinical trials required to collect evidence to support the benefits claimed (reducing impact of falls). Sample sizes to account for significant number of subjects continuing to live normally without any falls requiring intervention. Access to medical records/cost of treatment/health outcomes/discharge data/subsequent care pathways required

Kemuri collects accurate lifestyle data that can be used in clinical trials of drugs dispensed to people living independently including people with cognitive impairment/physical disability not able to record times of events/ambient conditions. KemuriSense power sockets can collect data for several years, in dementia trials it may be possible to identify rates of decline & use it to modify the care regime
What is the intellectual property status of your innovation?:
Kemuri has patents pending; GB1417259.7, effective date of 30 September 2014 and PCT/GB2015/000275, International Filing Date of 30 September 2015. 

Note that the patent applies to more devices than a power socket.  It covers the internal electronics and components, which could be incorporated into any equipment consuming significant amounts of power. 

Kemuri and KemuriSense are registered trademarks.  
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
3
Regulatory Approvals:
The KemuriSense Smart Power Socket has been tested for EMC (Electro Magnetic Compliance) and CE certification. 

The product only measures ambient conditions and does not require certification as a medical device.
Commercial information:
We are building batches of 100 for field trials with availability in January 2017. 

The projected sales shown in the table below.



The growth accelerates as more telecare resellers become customers.

Current and potential telecare users: The Strategic Society Centre undertook a major quantitative research project entitled Who uses telecare? published in 2012 to explore usage of telecare among older people in England and identify potential users of telecare. It provided a conservative estimate based on 2008 data that among the over-50s in England, there were well over 1 million telecare users. However, by mapping individuals with similar conditions, the report was able to identify around 2.5 million more individuals living alone who may be able to benefit from telecare, and potentially as many as 4.1 million with conditions that could merit the use of telecare.

Further, the report stated that around 30% to 50 % of current telecare users paid for their telecare themselves or with the help of a family member. Among private and non-privately funded telecare users, it appears there is little difference in incomes. This suggests that relatively low income is not a barrier to individuals and their families funding telecare themselves or that most users can contribute to the cost of telecare support.
The report made recommendations to policymakers to aim to boost the usage of telecare to at least double current prevalence focusing on individuals living alone. It also recommended that policymakers and the industry should focus on targeting informal carers, including both cohabiting and non-cohabiting family carers as potential beneficiaries of greater usage of telecare.

Global telecare market: The global telecare market is valued at c. £1 billion per annum and is forecast by the Deloitte Centre for Health Solutions to grow at a rate of 5% per annum from now to 2018. The factors contributing to growth and market attractiveness are related to government initiatives and funding and the public willingness and receptivity towards technological advancement. The UK is the leading market for telecare products and services, with the UK telecare market share of up to 25% of the global market. Other prominent markets for telecare in terms of ageing populations that demand such services include France, Italy and Benelux (comprising Belgium, Luxemburg and the Netherlands).

Ireland, Malta, Singapore, Hong-Kong, Malaysia and Saudi Arabia as potential overseas markets for KemuriSense®, as those territories use British standard socket outlets.
Investment activity:
Kemuri was founded by Dr Leonard Anderson, Russell Anderson and Michael Anderson in January 2014.  Together, they worked on the concept for an older person’s carer assistance solution after failing to find a suitable product and service on the market.  The Company’s activity to date has been focused on product and web-services development and has been funded from private and public sources.  Kemuri’s proof-of-concept project was successfully completed in October 2015, assisted by grants from Innovate UK; £66,734 for a Smart Grant and £5,000 for a Smart Voucher. A £2,000 prize from Kent County Council paid for the first smart power socket prototype. 

Dr Anderson has provided an unsecured director's loan facility of £100,000.

Innovate UK sponsored £5000 research with the Institute of Ageing at Newcastle University for the Ethics of Passive Monitoring.

The company raised £545,000 in a private offer via West Hill Capital.  The funds are being deployed to refine the core product infrastructure, to develop the mobile app, to recruit staff across operations and to build an online sales platform. 

Kemuri has been awarded with €100,000 as a partner in an Erasmus + project for people-centred centred design.  Our UK partner is Durham University together with others in Netherlands, Czech Republic and Slovenia

The Company is a growth business and will not be cash generative in the short term as it invests heavily in developing the business in order to generate long-term profitable business relationships.

A key requirement is to find funding for an academic study to collect evidence for the value of predictive analytics for a period of at least one year.  Grants are being sought from multiple sources.
Regional Scalability:
Smart power socket production is scalable (batches of 100-1000 p.m) in the Woking production facility (larger volumes achieved by second sourcing manufacture). The Web technology is cloud-based & can be rapidly scaled by commissioning more servers/storage at short notice. WM scale-up can be generated by raising awareness with the following:
  • Social Services Commissioners/OTs
  • GP Surgeries, Mental Health & Hospital Trusts
  • Housing Associations & Voluntary Sector eg AgeUK
  • Telecare Service Companies
  • Local media/online sales websites 
Welbeing, our telecare service partner’s clients include WM local authorities & housing associations, providing installation & call monitoring services to any new customers in the region.

As a start-up our effort is directed to delivering reliable hardware & software with small sample numbers. Our design objective is for KemuriSense power sockets to operate continuously for at least 5 years. First trials have started in County Durham housing associations.
Measures:
In co-operation with an academic research partner, we hope to achieve the following in a trial:

Quality
  • Continuous reliable operation
  • Avoidance of false alerts
  • Recognising unattended falls, strokes or other episodes that result in a carer taking action that saved time and cost for medical intervention.
  • Peace of mind achieved for families and carers
  • Identifying trends that indicate the risk of hypothermia, dehydration and malnutrition.
  • Identifying activity at unusual times of day that lead to helpful family or medical intervention 
Safety
  • Electrical safety of products after installation in kitchens.
  • Security of personal data and avoidance of data loss. 
Cost
The trial budget is £500,000.  This would include the costs of selection, installation, monitoring, service support and surveying families throughout the trial.  Note that his includes detailed data analysis, medical services, the final report and communications.
 
People
The target group for research is a cohort that has these attributes:
  • Reject pendant alarms
  • Deny declining capacity
  • Want to live independently
  • Show symptoms of dementia
  • Need daily monitoring
A percentage will be used as a control group who are not included in the Trial.  The total numbers are to agreed by the academic research partner from one of the West Midlands universities.
 
Ethics
Finding volunteer older people and their next of kin will require access to the medical records and adult social care records of older people living alone.  This will also be needed during the trial to measure the times and costs of medical treatment.  Approval by the Ethics Committee will be required.  
Adoption target:
Assuming that there are 500,000 unused pendants in the UK, there are approximately 40,000 candidates for Kemuri wellbeing monitoring in a West Midlands population of 5 million.   

500 is a reasonable target for 2017/2018 – with an possibility of growing to 10,000 in 5 years.  
Investment sought:
A total investment of £500,000 over two years would provide a trial that provides evidence for wider adoption in the Region.  For budgeting purposes, this breaks down as follows:
  • £40,000 - Project Management
  • £100,000 – Installation and Web services for 120 older people and their families
  • £50,000 – Health service costs
  • £250,000 – Academic research costs
  • £60,000 – Kemuri cost to support the trial. 
The findings should be applicable throughout the UK. 

The objective is to obtain SBRI funding for the project.  
Read more
Hide details
Leonard Anderson 11/01/2017 - 15:28 Archived 3 comments
0
0
Votes

The Assure personal monitoring and alert system (#2213)
Innovation 'Elevator Pitch':
The Assure helps people to keep their independent lifestyle in the knowledge that if they need help/assistance the people they choose to respond, be they family or friends will be alerted quickly.  It can also support hospital discharge & reablement.
Overview of Innovation:
The Assure personal monitoring & alert system gives people confidence that if anything happens to them, help is at hand.
 
Designed for reliability of service, simplicity of use & elegance of design, The Assure personal alarm system is easy to set up & users can access the Acticheck online dashboard via their computer, tablet or smartphone to easily manage their settings.  They can also give their family & friends peace of mind by giving them permission to see their information & activity online should they choose to.
 
The ‘fit & forget’ monitoring wristband, designed to be worn 24/7, is made from medical-grade silicone for a comfortable fit & can be adjusted to any wrist-size.  With a contemporary lightweight design that is comfortable to wear, water-resistant & has a long battery life, wearers do not feel stigmatised.
 
The Assure system links the wristband to the base unit that is connected via the internet to the Cloud-based Acticheck server.  It passes messages between the user’s wristband & the Cloud, & to their personal responder network when needed.
 
With four ways of triggering an alert & two chances to cancel the alert, The Assure covers a wide range of eventualities giving complete home & garden coverage. 
  • SOS alert button: call for help with a simple squeeze of the wristband
  • Continuous fall monitoring: The Assure wristband listens for an unusual impact followed by a lack of movement that could be a severe fall
  • Wellness checks at a time to suit:  set The Assure to buzz once or more a day to check that the user is well, press a single button to say they are OK
  • Daily emails: for those who want confirmation users are up & active
  • End-to-end checks: the system updates its status several times an hour giving confidence that the system is working & also checks the wristband is being worn so that the user is protected
  • An online dashboard: so the chosen responders can see the user’s activity in real time if permission is given to them 
When an alert is initiated The Assure system gives two chances for it to be cancelled by the user, if both are not responded to The Assure will start to call the people in their personal responder network one-by-one with an automated message until one accepts the alert.  They will then be told, emailed &/or texted the user’s location & confidential access instructions, along with any first responder instructions such as vital medication requirements.

For more information visit https://www.acticheck.com
https://youtu.be/ZUWpme1wKkk​
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health
Benefit to NHS:
National data shows that the number of hospital admissions amongst older people is increasing. Over the last 10 years hospital discharges (and therefore admissions) for those over 75 have been rising at a much faster rate than ageing trends in the population; almost four times faster (38% compared to 10%).
 
The growth in hospital readmissions has been higher still, up by 86% for those over 75. This national picture is supported by the results of research by Royal Voluntary Service: of 401 people over 75 who had been in hospital within the last 5 years, 13% had been readmitted within three months. (source: http://www.royalvoluntaryservice.org.uk/Uploads/Documents/Reports%20and%20Reviews/Going_home_alone.pdf)
 
The Assure helps people with long-term health and care needs to stay out of hospital or residential care for longer, thereby reducing costs to the NHS and social care by avoiding the need for more costly interventions whilst maximising outcomes for patients and service users.
 
The demographic and budgetary pressures mean that the health service has to find new and better ways to ensure that high quality services continue to be provided. Remote telemonitoring is a prime example of this innovation.
 
The Assure supports people to continue to live independently in their own homes with the peace of mind that an intervention can be made should they require help or assistance.  With earlier interventions helping prevent deterioration it can help to reduce unnecessary hospital admissions, giving confidence and reassurance to users, carers and families.
  • 1/3 of all UK households are older households*
  • 3.5 million 65+ live alone. This is 36% of all people aged 65+ in GB*
  • 2 million people over 75 live alone*
  • There are now 11.6 million people aged 65 or over in the UK*
  • Falls are the largest cause of emergency hospital admissions for older people, and significantly impact on long term outcomes, e.g. being a major precipitant of people moving from their own home to long-term nursing or residential care*
  • Falls account for up to 40% of ambulance call-outs to homes for people aged 65+,153 costing £115 per callout*
  • 38% of delayed transfers of care within participating organisations were on care of older people wards* 
* - taken from Age UK, Later Life in the United Kingdom, June 2016

http://www.ageuk.org.uk/Documents/EN-GB/Factsheets/Later_Life_UK_factsheet.pdf?dtrk=true
 
Benefit to WM population:
Within the last ten years’ hospital admissions for those over 75 have been rising at an even faster rate than ageing trends in the population: almost four times faster. Worryingly the growth in hospital readmissions has been higher still, up by 86 per cent for those over 75.

By supporting people effectively in the community, The Assure helps those with long-term health and care needs to stay out of hospital or residential care, thereby reducing costs to the NHS and social care by avoiding the need for more costly interventions whilst maximising outcomes for patients and service users.

Although technology alone is not the complete answer, it can make an enormous contribution to independent living and quality of life for people who choose to remain living in their own home The Assure helps to manage risk and support continued independence.
Current and planned activity: 
Future developments: Go Anywhere
We are already well on the path to developing a mobile app.  This links the wristband to the wearer’s smartphone which provides mobile data and location.  The current smartband has been designed to be upgraded to link to a smartphone.
 
Procurement / Adoption: -  We would like to see greater regional awareness and adoption of The Assure, working in partnership with providers to focus on individual patient outcomes and to effectively embed technology enabled care to deliver services that are truly person centred. 
What is the intellectual property status of your innovation?:
Patent granted. 
Fully CE Certified.
EN 300 220-2 v2.41
EN 301 489-1
EN 60950-1:2006 + A2: 2013
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
3
Read more
Hide details
Karl Gibbs 19/12/2016 - 16:58 Archived Login or Register to post comments
0
0
Votes

123next ›last »

Recent Activities

Clinical Research and Clinical Trial Collaborations has been moved from Initial Submission to Publish 1 month 2 days ago
The Real Birth Online Workshop: addressing the barriers to effective antenatal education has been moved from Initial Submission to Publish 1 month 1 week ago
Elaine Russell commented on Cera Care 1 month 1 week ago
Elaine Russell commented on Cera Care 1 month 1 week ago
Ravi Kumar commented on Continuing Healthcare Workflow Software: CHC2DST to underpin service transformation 3 months 1 week ago
Read more ...

Active Campaigns

EAHSN: Early cancer diagnosis and targeted treatment
Serendip Digital Health Incubator and Accelerator
Mental Health Integrated Urgent Care Project
Delaying and managing the onset of frailty
Innovation and Technology Payment (ITP)